Growth Metrics

Cytosorbents (CTSO) Shareholder's Equity Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -84.91%
Dec 31, 2025 -46.85%
Sep 30, 2025 -32.60%
Jun 30, 2025 -33.52%
Mar 31, 2025 -25.89%
Dec 31, 2024 -52.70%
Sep 30, 2024 -28.86%
Jun 30, 2024 -28.75%
Mar 31, 2024 -34.44%
Dec 31, 2023 -33.63%
Sep 30, 2023 -51.94%
Jun 30, 2023 -48.57%
Mar 31, 2023 -45.99%
Dec 31, 2022 -43.47%
Sep 30, 2022 -44.57%
Jun 30, 2022 -36.06%
Mar 31, 2022 -28.26%
Dec 31, 2021 -21.00%
Sep 30, 2021 -11.99%
Jun 30, 2021 205.83%
Mar 31, 2021 262.49%
Dec 31, 2020 2,217.57%
Sep 30, 2020 1,091.50%
Jun 30, 2020 110.72%
Mar 31, 2020 41.95%
Dec 31, 2019 -79.82%
Sep 30, 2019 -66.45%
Jun 30, 2019 -46.46%
Mar 31, 2019 3.93%
Dec 31, 2018 65.01%
Sep 30, 2018 111.86%
Jun 30, 2018 172.37%
Mar 31, 2018 1,019.83%
Dec 31, 2017 667.34%
Sep 30, 2017 587.13%
Jun 30, 2017 103.14%
Mar 31, 2017 -125.07%
Dec 31, 2016 -86.42%
Dec 31, 2015 41.79%
Dec 31, 2014 148.68%
Sep 30, 2014 20.67%
Jun 30, 2014 30.00%
Mar 31, 2014 39.19%
Dec 31, 2013 -22.71%
Sep 30, 2013 -1,241.34%
Jun 30, 2013 -2,327.29%
Mar 31, 2013 -2,330.01%
Dec 31, 2012 -15.21%
Sep 30, 2012 6.37%
Jun 30, 2012 -69.13%
Dec 31, 2011 -25.10%